-
公开(公告)号:US11670418B2
公开(公告)日:2023-06-06
申请号:US16372052
申请日:2019-04-01
Applicant: DexCom, Inc.
Inventor: Katherine Yerre Koehler , Esteban Cabrera, Jr. , Eric Cohen , Mark Dervaes , Rian Draeger , Sheryl Sadsarin Gaano , Thomas Hall , Paul Kramer , Shawn Larvenz , Michael Robert Mensinger , Paul Noble-Campbell , Andrew Attila Pal , Eli Reihman , Brian Christopher Smith , Angela Marie Traven
IPC: G16H20/60 , A61B5/145 , G16H40/67 , G16H40/63 , G16Z99/00 , A61B5/00 , H04L43/065 , H04L43/0817 , H04L67/12 , G16H20/17
CPC classification number: G16H40/67 , A61B5/002 , A61B5/0004 , A61B5/14503 , A61B5/14532 , A61B5/7271 , A61B5/7275 , A61B5/7282 , A61B5/742 , A61B5/743 , A61B5/7405 , A61B5/746 , A61B5/7435 , A61B5/7455 , G16H20/17 , G16H20/60 , G16H40/63 , G16Z99/00 , H04L43/065 , H04L43/0817 , H04L67/12 , A61B2560/0475
Abstract: The subject matter disclosed herein provides methods for presenting glucose level data. Glucose data for a patient may be received. A current glucose level and a rate of change of the current glucose level may be determined based on the received glucose data. A first interface may be displayed on a screen of a device. The first interface may include a unitary icon. The unitary icon may display the current glucose level and a visualization of the rate of change. Related apparatus, systems, techniques, and articles are also described.
-
公开(公告)号:US20230165534A1
公开(公告)日:2023-06-01
申请号:US17929576
申请日:2022-09-02
Applicant: Dexcom, Inc.
Inventor: Apurv U. Kamath , Aarthi Mahalingam , Ying Li , Mohammad Shariati , James H. Brauker , Mark C. Brister , Robert Boock
IPC: A61B5/00 , A61B5/145 , A61B5/1486 , A61B5/1495
CPC classification number: A61B5/7203 , A61B5/14532 , A61B5/14539 , A61B5/14865 , A61B5/1495 , A61B5/6848 , A61B5/725 , A61B5/743 , A61B5/7475 , A61B5/01
Abstract: Systems and methods for detecting noise episodes and processing analyte sensor data responsive thereto. In some embodiments, processing analyte sensor data includes filtering the sensor data to reduce or eliminate the effects of the noise episode on the signal.
-
公开(公告)号:US11653860B2
公开(公告)日:2023-05-23
申请号:US17100465
申请日:2020-11-20
Applicant: DexCom, Inc.
Inventor: Andrew Parker , Neha Vyas , Christopher Hannemann
CPC classification number: A61B5/14532 , A61B5/0004 , A61B5/0022 , A61B5/14503 , A61B5/6801 , A61B5/7267 , A61B5/7275 , A61B5/742 , A61B5/7405 , G16H10/60 , G16H40/67 , G16H50/20 , G16H50/70 , G16H20/30
Abstract: Recommendations based on continuous glucose monitoring (CGM) are described. Given the number of people that wear CGM systems and because CGM systems produce measurements continuously, a platform that provides a CGM system may have an enormous amount of data. This amount of data is practically, if not actually, impossible for humans to process. In implementations, a CGM platform includes a data analytics platform that obtains glucose measurements provided by a CGM system and also obtains additional data associated with a user. The data analytics platform processes these measurements and the additional data to predict a health indicator by using models. This prediction serves as a basis for generating a recommendation, such as a message recommending the user take action or adopt a behavior to mitigate a predicted negative health condition.
-
公开(公告)号:US20230148917A1
公开(公告)日:2023-05-18
申请号:US18056555
申请日:2022-11-17
Applicant: Dexcom, Inc.
Inventor: Peter C Simpson , Mark C Brister , Matthew D Wightlin
IPC: A61B5/145 , A61B5/1473 , A61B5/1486 , A61B5/00 , A61B5/1495 , A61B5/15 , A61B5/05 , A61B17/34
CPC classification number: A61B5/14532 , A61B5/0002 , A61B5/0004 , A61B5/05 , A61B5/0031 , A61B5/72 , A61B5/1411 , A61B5/1451 , A61B5/1473 , A61B5/1486 , A61B5/1495 , A61B5/6801 , A61B5/6833 , A61B5/6848 , A61B5/6849 , A61B5/14503 , A61B5/14507 , A61B5/14514 , A61B5/14546 , A61B5/14735 , A61B5/14865 , A61B5/68335 , A61B17/3468 , A61B5/150022 , A61M5/1723
Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
-
公开(公告)号:US11642054B2
公开(公告)日:2023-05-09
申请号:US16890901
申请日:2020-06-02
Applicant: DexCom, Inc.
Inventor: Ohseung Kwon , Xianyan Wang , Timothy Stowe
IPC: A61B5/145 , A61B5/1473 , A61B5/00
CPC classification number: A61B5/1473 , A61B5/1451 , A61B5/14532 , A61B5/14735 , A61B5/6833 , A61B2562/125
Abstract: In some aspects, an apparatus for a biosensor includes a sensor wire and a rigid member. The rigid member may be coupled to the sensor wire and include a contact surface. The contact surface may be sized to enable a suction head of a robotic placement device to create a vacuum seal on the contact surface for lifting the sensor wire and rigid member.
-
公开(公告)号:US11642049B2
公开(公告)日:2023-05-09
申请号:US16739617
申请日:2020-01-10
Applicant: DexCom, Inc.
Inventor: Phil Mayou , Hari Hampapuram , David Price , Keri Leone , Kostantyn Snisarenko , Michael Robert Mensinger , Leif N. Bowman , Robert J. Boock , Apurv Ullas Kamath , Eli Reihman , Peter C. Simpson
CPC classification number: A61B5/14532 , G16H15/00 , G16H50/20 , G16H50/70 , Y02A90/10
Abstract: Systems and methods for detecting and reporting patterns in analyte concentration data are provided. According to some implementations, an implantable device for continuous measurement of an analyte concentration is disclosed. The implantable device includes a sensor configured to generate a signal indicative of a concentration of an analyte in a host, a memory configured to store data corresponding at least one of the generated signal and user information, a processor configured to receive data from at least one of the memory and the sensor, wherein the processor is configured to generate pattern data based on the received information, and an output module configured to output the generated pattern data. The pattern data can be based on detecting frequency and severity of analyte data in clinically risky ranges.
-
公开(公告)号:US20230140143A1
公开(公告)日:2023-05-04
申请号:US17974290
申请日:2022-10-26
Applicant: Dexcom, Inc.
Inventor: Giada Acciaroli , Margaret A. Crawford , Mark Derdzinski , Lauren H. Jepson , Sarah Kate Pickus , Robert J. Dowd , Apurv U. Kamath
Abstract: Glucose measurements are received and features for corresponding time periods over a time window are generated, the features being values indicating whether the user has been engaging in beneficial diabetes management behaviors. Using the aggregated features patterns indicating that beneficial diabetes management behaviors are not being engaged in are identified. Potential behavior modification feedback is generated by including in the potential behavior modification feedback at least one behavior modification feedback, for each of the identified patterns, that a user could take to engage in beneficial diabetes management behavior. At least one of the potential behavior modification feedback is selected and displayed or otherwise presented to the user.
-
公开(公告)号:US20230139158A1
公开(公告)日:2023-05-04
申请号:US18089351
申请日:2022-12-27
Applicant: DexCom, Inc.
Inventor: Jiong Zou , Robert J. Boock , Andrew Trinin Dennis , Ted Tang Lee , Jeff T. Suri , David Sze , Mark A. Tapsak , Huashi Zhang , Shanger Wang
IPC: G01N27/327 , C12N11/089 , C12N11/093 , C12N11/08 , C08L39/06 , C08L69/00 , C08L75/04 , C12Q1/00 , A61B5/00 , A61B5/145 , A61B5/1486 , G01N33/66 , A61K31/045 , A61K31/137 , A61K31/46 , A61K31/465 , A61K31/485 , A61K31/515 , A61K31/56 , A61K33/00 , A61K36/185 , A61K38/28 , A61B5/1473
Abstract: Disclosed are devices for determining an analyte concentration (e.g., glucose). The devices comprise a sensor configured to generate a signal associated with a concentration of an analyte and a sensing membrane located over the sensor. The sensing membrane comprises an enzyme layer, wherein the enzyme layer comprises an enzyme and a polymer comprising polyurethane and/or polyurea segments and one or more zwitterionic repeating units. The enzyme layer protects the enzyme and prevents it from leaching from the sensing membrane into a host or deactivating.
-
公开(公告)号:US20230136127A1
公开(公告)日:2023-05-04
申请号:US18148950
申请日:2022-12-30
Applicant: Dexcom, Inc.
Inventor: Peter C. Simpson , James H. Brauker , Mark C. Brister , Paul Goode , Apurv U. Kamath , Aarthi Mahalingam , Jack Pryor , Matthew D. Wightlin , Victor Ha , Steve Masterson , Melissa A. Nicholas , John E. Nolting , James R. Petisce , Sean T. Saint , Vance E. Swanson , Kum Ming Woo
IPC: A61B5/145 , A61B5/1486 , A61B5/00 , A61B5/05 , A61B5/15 , A61B5/1473 , A61B5/1495 , A61B17/34
Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
-
公开(公告)号:US20230133195A1
公开(公告)日:2023-05-04
申请号:US17900372
申请日:2022-08-31
Applicant: DexCom, Inc.
Inventor: Alexander Michael Diener , Stacey Lynne Fischer , Harry Shaw Strothers , Chad M. Patterson , Justin Yuen , Apurv U. Kamath , Andrew Merrill Terry , Margaret A. Crawford , Mark Derdzinski , Sarah Kate Pickus , Lauren H. Jepson , Adam G. Noar , Douglas S. Kanter , Sonya Sokolash
Abstract: Glucose monitoring over phases and corresponding phased information display is described. A multi-phase glucose monitoring program that includes at least a first phase and a second phase is initiated. First glucose data of a user is obtained during the first phase of the multi-phase glucose monitoring program. The output of the first glucose data in a glucose monitoring user interface is prevented during the first phase of the multi-phase glucose monitoring program. Second glucose data of the user is then obtained during a second phase of the multi-phase glucose monitoring program. The second glucose data is output, in real-time, in the glucose monitoring user interface during the second phase of the multi-phase glucose monitoring program.
-
-
-
-
-
-
-
-
-